Posts Tagged ‘TTBD’

What happened at the OHSU Startup Symposium?

For the third consecutive year, TTBD hosted OHSU’s Annual Startup Symposium on Thursday, Nov. 6, for more than 200 participants in the OHSU Auditorium. The theme and focus of this year’s event “Changing Investment Landscape for Life Science Companies & Early Stage Technologies” brought local business experts and leaders as well as industry representatives and investors from out of state to connect and meet one-to-one with OHSU faculty and startup companies. This symposium provided an … Read More

TTBD Lunch & Learn: Basics of Starting a Company, Dec. 16

The office of Technology Transfer & Business Development presents: The basics of starting a company in an academic setting: Things you should know, follow or avoid Are you interested in starting a company based on your invention? The Director of Business Development, Jit Banerjee, and the Startup Development Associate, Daphne Emerson, will take you through the basic steps to starting a company based on your technology, including: IP protection and assessment Option or license negotiation … Read More

TTBD Industry Spotlight: Pitching to industry

Building partnerships between academic and corporate institutions is a mutually beneficial endeavor. These types of alliances have the potential to innovate and solve many medical, scientific, and health-related issues. Universities can bring a wealth of knowledge and research expertise, while partnering corporations provide the resources and connections necessary to help that research flourish. Although the paths to these partnerships can vary by institution, scientific alignment is the foundation of prosperous relationships. The pharmaceutical, medical device, … Read More

TTBD aims to bring together inventors, investors and industry

The OHSU Technology Transfer & Business Development (TTBD) office is trying to send a clear message: We’ve got some really cool inventions at OHSU, and we’re open for business. Two new articles from the Portland Business Journal have focused on the TTBD office and the importance of commercializing innovations coming out of universities. The first article titled “OHSU conferences aim to bring together inventors, investors and industry,” discussed the office’s efforts to give investors and industry … Read More

Tech Transfer Newsletter: Fall 2014

Check out the latest news in the office of Technology Transfer & Business Development (TTBD) In this issue, we discuss:  An OHSU startup company’s drug that reached FDA approval – Contrave, an anti-obesity drug that is receiving high praises Introducing the OHSU MedTech Alliance – A mechanism for potential investors and industry collaborators to identify OHSU medical technologies Learn more about industry and academic collaborations – What type of agreement is appropriate for you? 2014 TTBD Awards recap … Read More

TTBD Lunch & Learn: Keeping a Lab Notebook, Oct. 21

A laboratory notebook is critical to document research that may form the basis of a patentable invention. An accurate record can show who made the invention, the contributions of each inventor, and how the invention was made. Senior Technology Development Manager Michele Gunness will lead this seminar to present updates on patent law and best practices to maintain your laboratory notebook to assist your attorney when preparing a patent application and providing support to your … Read More

TTBD announces 2014 award winners

On Monday, October 6, Technology Transfer and Business Development (TTBD) hosted the 2014 TTBD Awards to recognize OHSU researchers who had technologies licensed or optioned in the last fiscal year as well as those who brought in top dollars from industry to support their research. The ceremony drew an enthusiastic crowd to the Portland State University lecture hall at the new Collaborative Life Sciences Building. We’d like to congratulate all of the researchers who were recognized at this year’s … Read More

Orexigen featured in the Portland Business Journal

You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU’s office of Technology Transfer & Business Development (TTBD) created a start-up company called Orexigen Therapeutics, Inc., with Michael Cowley, then a neuroscience researcher at the Oregon National Primate Research Center. Cowley’s work looks at the appetite-regulating pathways in the brain and how these pathways are affected by obesity. Orexigen Therapeutics became public in 2007, and now the … Read More

OHSU startup Orexigen earns FDA approval

The office of Technology Transfer and Business Development is happy to announce that a drug from  Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition. Contrave has two components: … Read More

Project funding available for biomedical commercialization, LOIs due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health. All applicants are strongly encouraged to take advantage of the Biomedical Innovation Program … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives